What is HCA Healthcare's revenue?

HCA Healthcare (HCA) generated $76.4B in revenue over the trailing twelve months, up 6.7% year over year.

Is HCA Healthcare profitable?

HCA Healthcare reported $6.8B in net income over the trailing twelve months, a 8.9% net margin.

What is HCA Healthcare's earnings per share?

HCA Healthcare's diluted EPS over the trailing twelve months is $29.04.

Where does HCA Healthcare's income statement data come from?

Every line is extracted from HCA Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

HCA Healthcare HCA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$19.11B-2.1%	$19.51B+1.8%	$19.16B+3.0%	$18.61B+1.6%	$18.32B+0.2%
General and administrative	$133M-13.1%	$153M+10.1%	$139M+6.9%	$130M+3.2%	$126M+5.0%
Compensation and benefits	$8.28B-0.9%	$8.36B0.0%	$8.36B+2.8%	$8.14B+1.8%	$8B+1.0%
Depreciation and amortization	$930M+2.1%	$911M+2.5%	$889M+3.0%	$863M+0.3%	$860M+0.5%
Goodwill impairment	——	$0—	$0—	$0—	$0—
Total costs & expenses	$16.82B-0.1%	$16.84B+0.6%	$16.74B+3.4%	$16.19B+1.2%	$15.99B-1.0%
Interest expense	$584M+2.1%	$572M+2.0%	$561M-1.2%	$568M+3.8%	$547M+3.6%
Income from equity method investments	$9M-64.0%	$25M+56.3%	$16M-15.8%	$19M+5.6%	$18M+80.0%
Income before income taxes	$2.29B-14.4%	$2.67B+10.5%	$2.42B+0.1%	$2.42B+3.8%	$2.33B+9.1%
Income tax expense	$430M-15.5%	$509M-1.2%	$515M-1.7%	$524M+4.4%	$502M+12.3%
Net income	$1.62B-13.7%	$1.88B+14.3%	$1.64B-0.6%	$1.65B+2.7%	$1.61B+12.0%
Net margin	8.5%-1.1pp	9.6%+1.0pp	8.6%-0.3pp	8.9%+0.1pp	8.8%+0.9pp
Net income attributable to noncontrolling interests	$237M-16.8%	$285M+9.6%	$260M+9.2%	$238M+10.7%	$215M-13.3%
Diluted earnings per share	$7.15-11.7%	$8.10+16.4%	$6.96+1.9%	$6.83+5.9%	$6.45+14.6%
Basic earnings per share	$7.25-11.9%	$8.23+16.7%	$7.05+2.0%	$6.91+6.0%	$6.52+14.4%
Weighted-average shares, diluted	226.7M-5.4%	239.5M+1.4%	236.2M-2.4%	241.9M-3.0%	249.4M-4.7%
Weighted-average shares, basic	223.6M-5.4%	236.4M+1.5%	232.9M-2.6%	239.2M-3.1%	246.9M-4.5%
Adjustments To Estimated Medicare And Medicaid Reimbursement Amounts And Disproportionate Share Funds Resulting In Net Increases To Revenues Related To Cost Reports Filed During Respective Year	——	$7.75M0.0%	$7.75M0.0%	$7.75M0.0%	$7.75M-26.2%
Adjustments To Estimated Reimbursement Amounts Resulting In Net Increases To Revenues Related To Primarily Cost Reports Filed During Previous Years	——	$8M0.0%	$8M0.0%	$8M0.0%	$8M-59.0%
Amortization Of Financing Costs And Discounts	$11M-8.3%	$12M+71.4%	$7M-50.0%	$14M+27.3%	$11M+22.2%
Amortization of capitalized software and acquired intangible assets	——	$3M0.0%	$3M0.0%	$3M0.0%	$3M-25.0%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	-$100M—	——	——	——	-$873M—
Charity Care	$5.51B+19.5%	$4.61B+11.6%	$4.13B+0.5%	$4.11B+12.8%	$3.64B-5.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$1.6B-15.4%	$1.89B+15.6%	$1.64B-3.9%	$1.7B+3.7%	$1.64B+14.8%
Less: comprehensive income attributable to noncontrolling interest	$237M-16.8%	$285M+9.6%	$260M+9.2%	$238M+10.7%	$215M-13.3%
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	$1.84B-15.6%	$2.18B+14.8%	$1.9B-2.3%	$1.94B+4.5%	$1.86B+10.6%
Cost To Charges Ratio	9.2%-0.4%	9.6%-0.4%	10%+0.3%	9.7%+0.1%	9.6%-0.5%
Federal	——	$387.75M0.0%	$387.75M0.0%	$387.75M0.0%	$387.75M+29.0%
Foreign	——	$3.25M0.0%	$3.25M0.0%	$3.25M0.0%	$3.25M-35.0%
Current State And Local Tax Expense Benefit	——	$62M0.0%	$62M0.0%	$62M0.0%	$62M+17.0%
Federal	——	$50.25M0.0%	$50.25M0.0%	$50.25M0.0%	$50.25M-49.0%
Deferred Foreign Income Tax Expense Benefit	——	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M-14.3%
Deferred and other income taxes	$435M—	——	$434M+11.9%	$388M-21.1%	$492M+453%
State	——	$7.75M0.0%	$7.75M0.0%	$7.75M0.0%	$7.75M0.0%
Depreciation	——	$877M0.0%	$877M0.0%	$877M0.0%	$877M+6.5%
Dividends, Common Stock, Cash	$176M+7.3%	$164M-3.0%	$169M-2.3%	$173M-2.8%	$178M+6.0%
Effect of exchange rate changes on cash, cash equivalents and restricted cash	-$2M—	——	——	——	$3M—
Income taxes at U.S. statutory rate of 21%	$0.19—	——	$0.24-0.8%	$0.24+11.6%	$0.22—
Effective Income Tax Rate Reconciliation Excluding Net Income Attributable To Noncontrolling Interests	21%—	——	——	——	23.8%—
Foreign operations	——	$0—	$0—	$0—	$0-100%
Effective Income Tax Rate Reconciliation Internal Restructuring Of Affiliates Percent	——	0%—	——	——	——
Effective Income Tax Rate Reconciliation Internal Restructuring Of Affiliates Amount	——	$0—	$0—	$0—	$0-100%
Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent	——	$0.010.0%	$0.010.0%	$0.010.0%	$0.01-4.5%
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent	——	0.5%—	——	——	——
Excess tax benefits associated with employee equity plans (in percent)	——	-0.6%—	——	——	——
State income taxes – net of federal income tax benefit	——	$0.010.0%	$0.010.0%	$0.010.0%	$0.01-4.2%
Changes in unrecognized tax benefits	——	-0.2%—	——	——	——
Share-Based Payment Arrangement, Expense, Tax Benefit	$103M+544%	$16M+33.3%	$12M+33.3%	$9M-62.5%	$24M+167%
Estimated Cost Of Charity Care	$507M+17.6%	$431M+5.6%	$408M+3.3%	$395M+12.9%	$350M-7.2%
Estimated Cost Of Uncompensated Care	$1.25B+0.5%	$1.25B+4.9%	$1.19B+6.5%	$1.12B+5.8%	$1.06B-7.9%
Estimated Implicit Price Concessions	——	$1.92B0.0%	$1.92B0.0%	$1.92B0.0%	$1.92B-1.3%
Facilities Insured By Wholly Owned Insurance Subsidiary For Losses Maximum Amount	——	$27.5M0.0%	$27.5M0.0%	$27.5M0.0%	$27.5M+37.5%
Acquired intangibles	——	$68.5M0.0%	$68.5M0.0%	$68.5M0.0%	$68.5M0.0%
Foreign Currency Translation Amortization And Other	——	-$4.5M0.0%	-$4.5M0.0%	-$4.5M0.0%	-$4.5M+18.2%
Gain/(loss) on dispositions, net	-$1M-102%	$41M+2,150%	-$2M+33.3%	-$3M-400%	$1M—
Goodwill Additions	——	$54.5M0.0%	$54.5M0.0%	$54.5M0.0%	$54.5M+28.2%
Goodwill And Other Intangible Assets Acquired During Period	——	$54.5M0.0%	$54.5M0.0%	$54.5M0.0%	$54.5M+28.2%
Goodwill impairment losses	——	$0—	$0—	$0—	$0—
Income Tax Examination Interest Expense Net Of Tax	——	——	——	——	——
Income tax examination, penalties and interest expense (benefit)	——	$6.75M0.0%	$6.75M0.0%	$6.75M0.0%	$6.75M-55.7%
Income tax expense related to remeasurement of deferred tax assets and liabilities	——	——	——	——	——
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	——	$516.25M0.0%	$516.25M0.0%	$516.25M0.0%	$516.25M+15.4%
Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount	——	$52.5M0.0%	$52.5M0.0%	$52.5M0.0%	$52.5M+11.7%
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	——	$750K0.0%	$750K0.0%	$750K0.0%	$750K+200%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	——	$57M0.0%	$57M0.0%	$57M0.0%	$57M+10.7%
Changes in unrecognized tax benefits	——	-$4.5M0.0%	-$4.5M0.0%	-$4.5M0.0%	-$4.5M+89.8%
Income Taxes Paid, Net	-$5M-100%	$1.51B+1,768%	$81M-40.4%	$136M+1,260%	$10M-97.2%
Accounts payable and other current liabilities	-$990M-255%	$637M-9.6%	$705M+118%	$324M+132%	-$1B-455%
Increase (Decrease) in Accounts Receivable	$463M+5.5%	$439M+1,856%	-$25M+96.1%	-$647M-298%	$327M-61.7%
Increase Decrease In Inventories And Other Operating Assets	-$80M-376%	$29M—	——	$67M-81.4%	$360M+340%
Interest Paid, Excluding Capitalized Interest, Operating Activity	$569M+11.4%	$511M-17.8%	$622M+16.3%	$535M-0.7%	$539M+1.1%
Lease Cost	——	$313.25M0.0%	$313.25M0.0%	$313.25M0.0%	$313.25M+0.6%
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders	$191M-2.6%	$196M-17.3%	$237M+36.2%	$174M-20.9%	$220M+21.5%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$830M+16.9%	-$999M+66.3%	-$2.97B+3.9%	-$3.09B-107%	-$1.5B+30.9%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$1.28B+2.7%	-$1.32B+5.1%	-$1.39B-11.0%	-$1.25B-21.2%	-$1.03B+23.3%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$2.01B-14.6%	$2.36B-46.6%	$4.42B+4.9%	$4.21B+155%	$1.65B-35.5%
Net Income Loss Attributable To Noncontrolling Interest	$237M-16.8%	$285M+9.6%	$260M+9.2%	$238M+10.7%	$215M-13.3%
Number of reportable segments	3—	——	——	——	3—
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Arising During Period Tax Expense	——	$1.75M0.0%	$1.75M0.0%	$1.75M0.0%	$1.75M-53.3%
Other Comprehensive Income Foreign Currency Translation Adjustment Tax Expense	$3M—	——	——	$10M+150%	$4M—
Other Comprehensive Income Loss Before Tax	-$25M-247%	$17M+255%	-$11M-119%	$58M+61.1%	$36M—
Foreign currency translation gains (losses)	-$21M—	——	——	$45M+73.1%	$26M+148%
Other comprehensive income (loss)	-$22M-283%	$12M+250%	-$8M-117%	$48M+60.0%	$30M—
Tax expense (benefit)	-$3M-160%	$5M+267%	-$3M-130%	$10M+66.7%	$6M+100%
Other Comprehensive Income Reclassified Interest Benefit On Derivatives Arising During Period Tax Expense	——	$500K0.0%	$500K0.0%	$500K0.0%	$500K—
Net unrealized gains (losses) on securities still held	-$1M-200%	$1M-50.0%	$2M-33.3%	$3M-25.0%	$4M—
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax	-$1M-200%	$1M-66.7%	$3M0.0%	$3M-50.0%	$6M—
Other Noncash Income (Expense)	-$67M-36.7%	-$49M-8.9%	-$45M+6.3%	-$48M+9.4%	-$53M+13.1%
Patient Care Costs	$16.25B-0.5%	$16.34B+0.9%	$16.2B+3.6%	$15.64B+1.1%	$15.47B+0.2%
Payments For Proceeds From Investments	-$103M-5.1%	-$98M-246%	$67M+615%	-$13M+53.6%	-$28M-193%
Payment for (Proceeds from) Other Investing Activity	$4M+122%	-$18M-325%	$8M+260%	-$5M-267%	$3M-40.0%
Payments for Repurchase of Common Stock	$1.57B-38.6%	$2.56B+2.4%	$2.5B-0.3%	$2.51B0.0%	$2.51B+47.4%
Payments of Debt Issuance Costs	$0-100%	$22M—	——	——	$57M—
Payments of Dividends	$183M+13.0%	$162M-2.4%	$166M-2.9%	$171M-5.0%	$180M+9.1%
Payments To Acquire Interest In Subsidiaries And Affiliates	$265M+636%	$36M+2.9%	$35M-64.6%	$99M-56.4%	$227M+440%
Payments to Acquire Property, Plant, and Equipment	$1.12B-24.8%	$1.49B+15.6%	$1.29B+9.5%	$1.18B+18.7%	$991M-22.9%
Payments to Noncontrolling Interests	$191M—	——	——	——	$220M—
Proceeds from principal business dispositions	$3M-96.7%	$92M+820%	$10M+66.7%	$6M-96.3%	$161M+906%
Debt issued (Note 13)	$0-100%	$3.24B—	——	——	$5.23B—
Financing — other	-$262M-509%	-$43M-43.3%	-$30M-36.4%	-$22M+75.6%	-$90M-69.8%
Proceeds From Repayments Of Lines Of Credit	$1.44B+385%	$296M+114%	$138M-91.1%	$1.55B+604%	$220M—
Professional And General Liability Claims Payments Net	——	$175.5M0.0%	$175.5M0.0%	$175.5M0.0%	$175.5M+17.0%
Profit Loss And Other Comprehensive Income	$1.84B-15.6%	$2.18B+14.8%	$1.9B-2.3%	$1.94B+4.5%	$1.86B+10.6%
Provisions For Losses Related To Professional Liability Risks	——	$162.75M0.0%	$162.75M0.0%	$162.75M0.0%	$162.75M+3.8%
Reinsurance For Professional Liability Risks Retention Level Of Amount	——	$8.75M0.0%	$8.75M0.0%	$8.75M0.0%	$8.75M0.0%
Reinsurance For Professional Liability Risks Retention Minimum Level Of Amount	——	$6.25M0.0%	$6.25M0.0%	$6.25M0.0%	$6.25M0.0%
Repayments of Long-Term Debt	$58M-96.3%	$1.56B+794%	$174M-90.1%	$1.77B-54.7%	$3.9B+5,986%
Revenue Ratio	100%0.0%	100%0.0%	100%0.0%	100%0.0%	100%0.0%
Self Insured Retention Amount	——	$3.75M0.0%	$3.75M0.0%	$3.75M0.0%	$3.75M0.0%
Stock-based compensation	$86M-14.0%	$100M-3.8%	$104M+5.1%	$99M+1.0%	$98M+15.3%
Expected volatility	——	33%—	——	——	——
Risk-free rate	——	4.3%—	——	——	——
Weighted-average dividend yield	——	0.9%—	——	——	——
Options canceled (in dollars per share)	——	$308.57—	——	——	——
Granted (in shares)	——	$329.80—	——	——	——
Exercised (in shares)	——	$125.10—	——	——	——
Value of shares repurchased	$1.58B-37.5%	$2.53B+0.3%	$2.52B-0.3%	$2.53B+0.1%	$2.53B+50.0%
Stock Repurchased During Period Shares	3.2M-88.2%	26.7M—	——	——	7.8M-56.4%
Stockholders Equity Period Increase Decrease Other	$22M+375%	-$8M+27.3%	-$11M-192%	$12M-42.9%	$21M0.0%
Supplies Expense	$2.85B-4.2%	$2.98B+7.0%	$2.78B-2.2%	$2.84B+2.9%	$2.76B-1.0%
Tax Cuts And Jobs Act Of2017Income Tax Examination Change In Tax Rate	——	——	——	——	——
Tax Cuts And Jobs Act Of2017Income Tax Examination Interest Expense Net Of Tax	——	——	——	——	——
Average price paid (in dollars per share)	$497.63+32.9%	$374.54—	——	——	$322.84-4.4%
Uncompensated Care	$13.61B+2.1%	$13.33B+11.0%	$12.02B+3.4%	$11.63B+5.7%	$10.99B-5.7%
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions	——	$750K0.0%	$750K0.0%	$750K0.0%	$750K-98.5%
Unrecognized tax benefits, settlements	——	$250K0.0%	$250K0.0%	$250K0.0%	$250K-94.1%
Unrecognized Tax Benefits Increase Decrease Resulting From Current Period Tax Positions	——	$5.25M0.0%	$5.25M0.0%	$5.25M0.0%	$5.25M-47.5%
Additions for tax positions of prior years	——	$6.25M0.0%	$6.25M0.0%	$6.25M0.0%	$6.25M-60.3%
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations	——	$6.75M0.0%	$6.75M0.0%	$6.75M0.0%	$6.75M+80.0%
Add: dilutive effect of potential common shares (in shares)	$3.06M+1,187%	$238K-92.8%	$3.29M+20.2%	$2.74M+9.3%	$2.5M—
EBIT	$2.87B-11.5%	$3.24B+8.9%	$2.98B-0.1%	$2.98B+3.8%	$2.87B+8.0%
EBITDA	$3.8B-8.5%	$4.16B+7.4%	$3.87B+0.6%	$3.85B+3.0%	$3.73B+6.2%
EBITDA	$3.8B-8.5%	$4.16B+7.4%	$3.87B+0.6%	$3.85B+3.0%	$3.73B+6.2%
EBITDA margin	19.9%-1.4pp	21.3%+1.1pp	20.2%-0.5pp	20.7%+0.3pp	20.4%+1.1pp
EBIT	$2.87B-11.5%	$3.24B+8.9%	$2.98B-0.1%	$2.98B+3.8%	$2.87B+8.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about HCA Healthcare.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is HCA Healthcare's revenue?: HCA Healthcare (HCA) generated $76.4B in revenue over the trailing twelve months, up 6.7% year over year.
Is HCA Healthcare profitable?: HCA Healthcare reported $6.8B in net income over the trailing twelve months, a 8.9% net margin.
What is HCA Healthcare's earnings per share?: HCA Healthcare's diluted EPS over the trailing twelve months is $29.04.
Where does HCA Healthcare's income statement data come from?: Every line is extracted from HCA Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.